Waters Corporation $WAT Shares Sold by Baldwin Wealth Partners LLC MA

Key Points

• Baldwin Wealth Partners LLC reduced its stake in Waters Corporation by 4.6%, selling 1,181 shares and now holding 24,332 shares valued at approximately $8.49 million.
• Waters recently reported earnings of $2.95 per share, exceeding expectations, with revenue of $771.33 million, marking an 8.8% year-over-year increase.
• Analysts have set various price targets for the stock, with a consensus target price of $377.56 and ratings ranging from "Strong Buy" to "Neutral."

Baldwin Wealth Partners LLC MA lessened its position in Waters Corporation (NYSE:WAT - Free Report) by 4.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,332 shares of the medical instruments supplier's stock after selling 1,181 shares during the period. Baldwin Wealth Partners LLC MA's holdings in Waters were worth $8,493,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of WAT. Olde Wealth Management LLC acquired a new stake in shares of Waters in the 1st quarter worth about $25,000. Zions Bancorporation National Association UT bought a new position in Waters in the 1st quarter valued at about $28,000. IFP Advisors Inc grew its position in Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after buying an additional 44 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Waters in the 1st quarter valued at about $41,000. Finally, Steph & Co. bought a new position in Waters in the 2nd quarter valued at about $73,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Rothschild Redb upgraded shares of Waters to a "strong-buy" rating in a research report on Wednesday. JPMorgan Chase & Co. increased their target price on shares of Waters from $300.00 to $325.00 and gave the company a "neutral" rating in a research report on Thursday. Scotiabank reiterated a "sector outperform" rating and issued a $465.00 target price on shares of Waters in a research report on Friday, July 11th. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Finally, UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $377.56.

Waters Stock Performance

NYSE:WAT opened at $330.48 on Friday. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The company has a 50-day moving average of $299.15 and a 200-day moving average of $324.44. The firm has a market cap of $19.67 billion, a price-to-earnings ratio of 29.80, a price-to-earnings-growth ratio of 3.05 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $771.33 million during the quarter, compared to analyst estimates of $745.96 million. During the same quarter last year, the firm posted $2.63 EPS. The business's revenue for the quarter was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.